CVR number 16172804
Industry 869500

FAABORG FYSIOTERAPI ApS. AUTORISERET FYSIOTERAPEUT

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.2% 6.5% 6.2% 9.3% 7.3%  
Credit score (0-100)  26 35 37 25 33  
Credit rating  BB BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  2,915 3,829 4,021 4,172 3,830  
EBITDA  127 351 491 854 629  
EBIT  89.7 316 458 821 597  
Pre-tax profit (PTP)  63.4 296.7 439.3 815.9 583.4  
Net earnings  47.9 231.3 342.3 636.3 454.2  
Pre-tax profit without non-rec. items  63.4 297 439 816 583  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  208 173 140 107 74.7  
Shareholders equity total  308 489 601 888 712  
Interest-bearing liabilities  170 309 145 0.0 0.0  
Balance sheet total (assets)  1,130 1,392 1,223 1,375 1,027  
Net Debt  162 300 123 -126 -209  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,915 3,829 4,021 4,172 3,830  
Gross profit growth  -14.0% 31.3% 5.0% 3.8% -8.2%  
Employees  5 6 6 6 7  
Employee growth %  0.0% 20.0% 0.0% 0.0% 16.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,130 1,392 1,223 1,375 1,027  
Balance sheet change%  -14.4% 23.1% -12.2% 12.5% -25.3%  
Added value  126.9 351.4 490.5 854.1 629.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -45 -71 -65 -65 -65  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  3.1% 8.3% 11.4% 19.7% 15.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.3% 26.4% 36.5% 65.4% 51.2%  
ROI %  13.7% 50.2% 60.1% 101.8% 75.6%  
ROE %  10.8% 58.0% 62.8% 85.5% 56.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  27.2% 35.1% 49.2% 64.6% 69.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  128.0% 85.5% 25.0% -14.8% -33.2%  
Gearing %  55.3% 63.2% 24.1% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  14.2% 14.9% 16.4% 46.2% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.1 1.4 1.8 2.7 3.1  
Current Ratio  1.2 1.4 1.8 2.7 3.1  
Cash and cash equivalent  7.9 8.9 22.3 126.0 208.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  125.2 339.3 480.8 795.4 647.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  25 59 82 142 90  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  25 59 82 142 90  
EBIT / employee  18 53 76 137 85  
Net earnings / employee  10 39 57 106 65